Zimmer Biomet Announces First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Zimmer Biomet (ZBH) PT Lowered to $130 at RBC Capital
April 27, 2018 9:02 AM EDTRBC Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $140.00) while maintaining a Outperform rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $146 at Needham & Company
April 27, 2018 6:28 AM EDTNeedham & Company lowered its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $155.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "ZBH's 1Q18 revenue and EPS beat consensus. Management's 2018 revenue guidance was above consensus while its EPS guidance was slightly below... More
Zimmer Biomet (ZBH) PT Lowered to $130 at Jefferies; 'Putting in the Bottom?'
April 26, 2018 1:44 PM EDTJefferies lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $141.00) while maintaining a Buy rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $137 at BMO Capital; 'Making Very Early Progress, Resetting the Bar'
April 26, 2018 1:17 PM EDTBMO Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $137.00 (from $144.00) while maintaining a Outperform rating.
... MoreZimmer Biomet (ZBH) PT Raised to $117.50 at Evercore ISI
April 26, 2018 1:05 PM EDTEvercore ISI raised its price target on Zimmer Biomet (NYSE: ZBH) to $117.50 (from $115.00) while maintaining a In Line rating.
What analsyt Vijay Kumar liked:
Management is confident on the supply recovery turnaround in July that will help accelerate sales growth... More


